Europe launches investigation into health risks of faulty breast implantsBMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e939 (Published 07 February 2012) Cite this as: BMJ 2012;344:e939
- Rory Watson
The European Commission has launched an in-depth scientific investigation into the potential risks to health of faulty breast implants. While preparing to update existing legislation, it will also examine with national authorities how surveillance of medical devices can be strengthened under the present rules.
The initiatives were taken after the Scientific Committee on Emerging and Newly Identified Health Risks concluded, in an opinion published on 2 February, that there were insufficient data to draw firm conclusions on the potential health risk to women with Poly Implant Prosthèse (PIP) silicone breast implants.
The committee, an independent advisory body with expertise in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial